₹191.03
₹-3.89 (-2.00%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹757 Cr
P/E
51.55
ROE
7.46%
ROCE
9.58%
About Amanta Healthcare Ltd
Amanta Healthcare are a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal (“ABFS”) and Injection Strech Blow Moulding (“ISBM”) technology. We manufacture large volume parenterals (“LVPs”) and small volume parenterals (“SVPs”) in six therapeutic segments. In addition to that, we also manufacturer medical devices. We manufacture fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc.
Founded
1994
CEO
Bhavesh Patel
Employees
1,718
HQ
Ahmedabad, Gujarat
About Amanta Healthcare Ltd
Amanta Healthcare are a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal (“ABFS”) and Injection Strech Blow Moulding (“ISBM”) technology. We manufacture large volume parenterals (“LVPs”) and small volume parenterals (“SVPs”) in six therapeutic segments. In addition to that, we also manufacturer medical devices. We manufacture fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc.
Founded:1994
CEO:Bhavesh Patel
Employees:1,718
HQ:Ahmedabad, Gujarat
Finished Products
1Sale of Products
₹806.34Cr2Sales of Services
₹5.17Cr3Export Incentive
₹1.39Cr4Scrap sales
₹1.28CrRaw Materials
1Cost of Material Consumed
₹250.95Cr2Purchase of Stock in Trade
₹15.07CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹206
52W Low
₹92
Volume15.13K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
51.55x
Valuation
P/B Ratio
3.44x
Valuation
EPS
₹3.78
Valuation
Dividend Yield
0.00%
Valuation
ROE
7.46%
Profitability
ROCE
9.58%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing and sale of pharmaceuRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
66.6%
International
33.4%
India66.6%
Outside India33.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
1.11x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
0.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.